These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 38081559

  • 41. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W, Rades T, Rantanen J, Yang M.
    Int J Pharm; 2019 Jun 30; 565():1-8. PubMed ID: 30999050
    [Abstract] [Full Text] [Related]

  • 42. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
    Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D.
    Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834
    [Abstract] [Full Text] [Related]

  • 43. Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
    Khanal D, Kim J, Zhang J, Ke WR, Holl MMB, Chan HK.
    Int J Pharm; 2023 Feb 05; 632():122563. PubMed ID: 36586629
    [Abstract] [Full Text] [Related]

  • 44. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K, Srichana T.
    Pharm Dev Technol; 2016 Feb 05; 21(1):68-75. PubMed ID: 25331092
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 05; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 48. Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infection.
    Adhikari BR, Sinha S, Gordon KC, Das SC.
    Int J Pharm; 2022 Jun 10; 621():121799. PubMed ID: 35525472
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization.
    Rashid MA, Muneer S, Wang T, Alhamhoom Y, Rintoul L, Izake EL, Islam N.
    PLoS One; 2021 Jun 10; 16(4):e0249683. PubMed ID: 33848310
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F, Ghanbarzadeh S, Safdari R, Yaqoubi S, Adibkia K, Hamishehkar H.
    Drug Res (Stuttg); 2020 Jan 10; 70(1):26-32. PubMed ID: 31533157
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J, Yuan H, Yu S, Mao S, Tony Zhou Q.
    Int J Pharm; 2022 Jun 25; 622():121859. PubMed ID: 35643348
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
    Sinsuebpol C, Chatchawalsaisin J, Kulvanich P.
    Drug Des Devel Ther; 2013 Jun 25; 7():861-73. PubMed ID: 24039397
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.